CNBC Halftime Report Final Trades: Bristol-Myers Squibb, Pfizer, Textron, Oracle
Portfolio Pulse from Benzinga Newsdesk
The CNBC Halftime Report highlighted final trades including Bristol-Myers Squibb, Pfizer, Textron, and Oracle.
July 30, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bristol-Myers Squibb was highlighted as a final trade on CNBC's Halftime Report.
Being highlighted on a popular financial show like CNBC's Halftime Report can generate increased investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Oracle was highlighted as a final trade on CNBC's Halftime Report.
Being highlighted on a popular financial show like CNBC's Halftime Report can generate increased investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Pfizer was highlighted as a final trade on CNBC's Halftime Report.
Being highlighted on a popular financial show like CNBC's Halftime Report can generate increased investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Textron was highlighted as a final trade on CNBC's Halftime Report.
Being highlighted on a popular financial show like CNBC's Halftime Report can generate increased investor interest and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80